Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 13 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 10265394

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    The Regents of the University of California · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  2. US 10258682

    Attenuated chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  3. US 10238734

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    The Regents of the University of California · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  4. US 10232035

    Conditionally replication deficient herpes virus and use thereof in vaccines

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  5. US 10233429

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  6. US 10232030

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  7. US 10226523

    Clostridium difficile vaccine and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  8. US 10226526

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  9. US 10226521

    Genetically modified Yersinia as vaccines against Yersinia species

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  10. US 10220082

    WT1 vaccine

    Inovio Pharmaceuticals, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  11. US 10206995

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  12. US 10197577

    Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  13. US 10172932

    Ebola virus disease vaccine taking human replication deficient adenovirus as vector

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  14. US 10172933

    Mosaic vaccines for serotype a foot-and-mouth disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  15. US 10172930

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  16. US 10167320

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  17. US 10166288

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  18. US 10160957

    Development of dengue virus vaccine components

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  19. US 10137186

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  20. US 10130705

    Vaccines with interleukin-33 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  21. US 10130700

    Polyvalent influenza virus-like particles (VLPS) and use as vaccines

    The United States of America, as represented by the Secretary, DHHS · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  22. US 10130696

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  23. US 10111950

    Modified glycolipids and methods of making and using the same

    VACCINEX, INC. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  24. US 10105436

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.